B
BioAxone BioSciences, Inc.
Profile managed by Bizz IdBioAxone
Estados Unidos
1-10 employees
2011
Description
Biopharmaceutical company founded in 2011 in Cambridge, MA, dedicated to developing drug candidates for neurotrauma and neurovascular disorders. Pipeline: Rho inhibitor (BA-210/VX-210, Phase 2b/3 licensed to Vertex), BA-434 (sd-rxRNA for spinal cord injury), and ROCK2 inhibitor licensed to Neurelis.